Electroporation Potentiated Immunotherapy in Cancer
Clinical trial NCT04835402 · UNKNOWN
Trial details
- NCT number
- NCT04835402
- Sponsor
- Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-26
- Primary completion
- 2022-03-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.